Nibec

Jecheon-si, South Korea Founded: 2004 • Age: 22 yrs
Peptide-based products for tissue regeneration are developed and provided.
Request Access
Report Incorrect Data
Annual revenue $16.6M Latest available
Total funding - 1 rounds
Employees 96 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Nibec

Nibec is a company based in Jecheon-si (South Korea) founded in 2004. The company has 96 employees as of December 31, 2024. Nibec operates in a competitive market with competitors including Sonendo, Young Innovations, Changzhou Sail Medical Technology, Odne and Neolix, among others.

  • Headquarter Jecheon-si, South Korea
  • Employees 96 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Nibec Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies → →
Key Metrics
  • Annual Revenue
    $16.64 M (USD)
    56.33
    as on Dec 31, 2024
  • Net Profit
    -$6.33 M (USD)
    -48.42
    as on Dec 31, 2024
  • EBITDA
    -$1.14 M (USD)
    -246.44
    as on Dec 31, 2024
  • Latest Funding Round
    $5.22 M (USD), Post-IPO

    Mar 31, 2016

  • Investors
  • Employee Count
    96

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Nibec

Nibec is a publicly listed company on the KRX with ticker symbol 138610 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 138610 · Sector: Health technology · South Korea

Funding Insights of Nibec

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $5.2M
  • First Round

    (31 Mar 2016)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2016 Amount Post-IPO - Nibec Valuation

investors

Investments & Acquisitions by Nibec

Investments

Financial Statements - Nibec

Nibec Comparisons

+
Add Comparison
Available on Premium

Competitors of Nibec

Nibec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sonendo, Young Innovations, Changzhou Sail Medical Technology, Odne and Neolix, among others.

Company Name Domain Founded year HQ Location Description
Sonendo
domain founded_year HQ Location
Therapy devices and software for treating tooth decay are developed.
Young Innovations
domain founded_year HQ Location
Portfolio of dental equipment
Changzhou Sail Medical Technology
domain founded_year HQ Location
Dental equipment and CBCT systems are manufactured in Changzhou, China.
Odne
domain founded_year HQ Location
Medical devices for root canal treatments are developed by Odne.
Neolix
domain founded_year HQ Location
Dental surgical instruments for endodontics are designed, manufactured, and marketed.
Kuraray
domain founded_year HQ Location
Kuraray is engaged in producing specialty chemicals and materials.

Latest news on Nibec

Nibec gets approval for its bone graft biomaterials in Colombia, Mexico
Kedglobal • 3 years ago

Frequently Asked Questions about Nibec

Nibec was founded in 2004 and raised its 1st funding round 12 years after it was founded.

Nibec is headquartered in Jecheon-si, South Korea. It is registered at Jecheon-si, Chungcheongbuk-do, South Korea.

As of Dec 31, 2024, the latest employee count at Nibec is 96.

Annual revenue of Nibec is $16.64M as on Dec 31, 2024.

Nibec was founded in 2004 in South Korea. Medical and pharmaceutical products are offered, including oral care items, biomaterials for tissue regeneration, peptide-based bio fusion solutions, and cosmetics. Technologies such as peptide discovery methods, drug delivery systems, and tissue regenerative approaches are employed. FDA 510(k) clearance has been secured for several products, supporting applications in healthcare and related sectors.

Nibec's top competitors include Sonendo, ZimVie and Odne.

Yes, Nibec is publicly traded on KRX under the ticker symbol 138610.

The ticker symbol of Nibec is 138610 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available